HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edyta Cędrowska Selected Research

substance P (5-11)

1/2018Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy.
4/2017Nanozeolite bioconjugates labeled with 223Ra for targeted alpha therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edyta Cędrowska Research Topics

Disease

2Glioma (Gliomas)
01/2018 - 04/2017
1Breast Neoplasms (Breast Cancer)
02/2020
1Ovarian Neoplasms (Ovarian Cancer)
02/2020
1Hyperthermia
02/2020

Drug/Important Bio-Agent (IBA)

2Radioisotopes (Radionuclides)IBA
02/2020 - 01/2018
2substance P (5-11)IBA
01/2018 - 04/2017
2Peptide FragmentsIBA
01/2018 - 04/2017
1AcidsIBA
02/2020
1Pharmaceutical PreparationsIBA
02/2020
1Trastuzumab (Herceptin)FDA Link
02/2020
1Monoclonal AntibodiesIBA
02/2020
1Silar (3M) (Silan)IBA
01/2018
1Substance PIBA
04/2017
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
04/2017
1SolutionsIBA
04/2017

Therapy/Procedure

2Therapeutics
02/2020 - 01/2018
1Radioimmunotherapy
02/2020